These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 27011234)
1. Effects of Latanoprost and Bimatoprost on the Expression of Molecules Relevant to Ocular Inflow and Outflow Pathways. Li X; He F; Gabelt BT; Wang Y; Cai S; Cao J; Fan N; Kaufman PL; Liu X PLoS One; 2016; 11(3):e0151644. PubMed ID: 27011234 [TBL] [Abstract][Full Text] [Related]
2. The effects of prostaglandin analogues on IOP in prostanoid FP-receptor-deficient mice. Ota T; Aihara M; Narumiya S; Araie M Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4159-63. PubMed ID: 16249494 [TBL] [Abstract][Full Text] [Related]
3. Effect of bimatoprost, latanoprost, and unoprostone on matrix metalloproteinases and their inhibitors in human ciliary body smooth muscle cells. Ooi YH; Oh DJ; Rhee DJ Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5259-65. PubMed ID: 19443729 [TBL] [Abstract][Full Text] [Related]
4. Bimatoprost, latanoprost, and tafluprost induce differential expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases. Yamada H; Yoneda M; Gosho M; Kato T; Zako M BMC Ophthalmol; 2016 Mar; 16():26. PubMed ID: 26956170 [TBL] [Abstract][Full Text] [Related]
5. Stanniocalcin-1 Is an Ocular Hypotensive Agent and a Downstream Effector Molecule That Is Necessary for the Intraocular Pressure-Lowering Effects of Latanoprost. Roddy GW; Viker KB; Winkler NS; Bahler CK; Holman BH; Sheikh-Hamad D; Roy Chowdhury U; Stamer WD; Fautsch MP Invest Ophthalmol Vis Sci; 2017 May; 58(5):2715-2724. PubMed ID: 28538979 [TBL] [Abstract][Full Text] [Related]
6. Additivity of bimatoprost or travoprost to latanoprost in glaucomatous monkey eyes. Gagliuso DJ; Wang RF; Mittag TW; Podos SM Arch Ophthalmol; 2004 Sep; 122(9):1342-7. PubMed ID: 15364714 [TBL] [Abstract][Full Text] [Related]
7. Effect of bimatoprost on patients with primary open-angle glaucoma or ocular hypertension who are nonresponders to latanoprost. Gandolfi SA; Cimino L Ophthalmology; 2003 Mar; 110(3):609-14. PubMed ID: 12623831 [TBL] [Abstract][Full Text] [Related]
8. Effect of prostaglandin analogs: Latanoprost, bimatoprost, and unoprostone on matrix metalloproteinases and their inhibitors in human trabecular meshwork endothelial cells. Heo JY; Ooi YH; Rhee DJ Exp Eye Res; 2020 May; 194():108019. PubMed ID: 32222455 [TBL] [Abstract][Full Text] [Related]
9. The Effect of Prostaglandin Analogues on the Ciliary Zonular Fibers of the Rabbit Crystalline Lens. Hwang HB; Kim SY Curr Eye Res; 2018 Nov; 43(11):1357-1361. PubMed ID: 30015523 [TBL] [Abstract][Full Text] [Related]
10. A comparison of bimatoprost 0.03% versus the fixed-combination of latanoprost 0.005% and timolol 0.5% in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label trial. Facio AC; Reis AS; Vidal KS; de Moraes CG; Suzuki R; Hatanaka M; Susanna R J Ocul Pharmacol Ther; 2009 Oct; 25(5):447-51. PubMed ID: 19860553 [TBL] [Abstract][Full Text] [Related]
11. Latanoprost induces matrix metalloproteinase-1 expression in human nonpigmented ciliary epithelial cells through a cyclooxygenase-2-dependent mechanism. Hinz B; Rösch S; Ramer R; Tamm ER; Brune K FASEB J; 2005 Nov; 19(13):1929-31. PubMed ID: 16076963 [TBL] [Abstract][Full Text] [Related]
12. Morphological changes in the anterior eye segment after long-term treatment with different receptor selective prostaglandin agonists and a prostamide. Richter M; Krauss AH; Woodward DF; Lütjen-Drecoll E Invest Ophthalmol Vis Sci; 2003 Oct; 44(10):4419-26. PubMed ID: 14507888 [TBL] [Abstract][Full Text] [Related]
13. A dual acting compound with latanoprost amide and nitric oxide releasing properties, shows ocular hypotensive effects in rabbits and dogs. Impagnatiello F; Borghi V; Gale DC; Batugo M; Guzzetta M; Brambilla S; Carreiro ST; Chong WK; Prasanna G; Chiroli V; Ongini E; Krauss AH Exp Eye Res; 2011 Sep; 93(3):243-9. PubMed ID: 21356209 [TBL] [Abstract][Full Text] [Related]
14. A case hypersensitive to bimatoprost and dexamethasone. Li X; Liu G; Wang Y; Yu W; Xiang H; Liu X J Ocul Pharmacol Ther; 2011 Oct; 27(5):519-23. PubMed ID: 21936632 [TBL] [Abstract][Full Text] [Related]
15. Comparison of human ocular distribution of bimatoprost and latanoprost. Ichhpujani P; Katz LJ; Hollo G; Shields CL; Shields JA; Marr B; Eagle R; Alvim H; Wizov SS; Acheampong A; Chen J; Wheeler LA J Ocul Pharmacol Ther; 2012 Apr; 28(2):134-45. PubMed ID: 22136089 [TBL] [Abstract][Full Text] [Related]
16. A randomized, investigator-masked comparison of diurnal responder rates with bimatoprost and latanoprost in the lowering of intraocular pressure. Choplin N; Bernstein P; Batoosingh AL; Whitcup SM; Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S19-25. PubMed ID: 15016558 [TBL] [Abstract][Full Text] [Related]
17. Effects of oxidative stress in trabecular meshwork cells are reduced by prostaglandin analogues. Yu AL; Fuchshofer R; Kampik A; Welge-Lüssen U Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4872-80. PubMed ID: 18971427 [TBL] [Abstract][Full Text] [Related]
18. Effect of travoprost, latanoprost and bimatoprost PGF2α treatments on the biomechanical properties of in-vivo rabbit cornea. Wang J; Zhao Y; Yu A; Wu J; Zhu M; Jiang M; Li X; Zhu D; Zhang P; Zheng X; Bao F; Elsheikh A Exp Eye Res; 2022 Feb; 215():108920. PubMed ID: 35007519 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of switching from topical latanoprost to bimatoprost in patients with normal-tension glaucoma. Sato S; Hirooka K; Baba T; Mizote M; Fujimura T; Tenkumo K; Ueda H; Shiraga F J Ocul Pharmacol Ther; 2011 Oct; 27(5):499-502. PubMed ID: 21790301 [TBL] [Abstract][Full Text] [Related]
20. A comparison of long-term intraocular pressure fluctuation in patients treated with bimatoprost or latanoprost. Simmons ST; Bernstein P; Hollander DA Am J Ophthalmol; 2008 Sep; 146(3):473-7. PubMed ID: 18561893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]